Cletus A. Arciero

Cletus A. Arciero

Auto-generated profile, based on publicly available information

Cletus A. Arciero

Department of Surgery Winship Cancer Institute of Emory University Atlanta Georgia USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Clinical Breast Cancer
Verified
Journal Article
Closed access
CACletus A. Arciero
Cletus A. Arciero
YGYi Guo
Yi Guo
RJRenjian Jiang
Renjian Jiang
MBMadhusmita Behera
Madhusmita Behera
RORuth O’rEgan
Ruth O’rEgan
XLXiaoxian Li
Xiaoxian Li

8 May 2019 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
CACletus Arciero
Cletus Arciero
YLYuan Liu
Yuan Liu
TGTheresa Gillespie
Theresa Gillespie
PSPreeti Subhedar
Preeti Subhedar

15 July 2020 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
CACletus A. Arciero
Cletus A. Arciero
ADAlbert H. Diehl
Albert H. Diehl
YLYuan Liu
Yuan Liu
QSQin Sun
Qin Sun
TGTheresa Gillespie
Theresa Gillespie
PSPreeti Subhedar
Preeti Subhedar

3 October 2022 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
OFOluwadamilola M. Fayanju
Oluwadamilola M. Fayanju
CEChristine E. Edmonds
Christine E. Edmonds
SRSylvia A. Reyes
Sylvia A. Reyes
CACletus Arciero
Cletus Arciero
VBVivian J. Bea
Vivian J. Bea
KJKathie-Ann Joseph
Kathie-Ann Joseph

30 August 2017 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
CACletus A. Arciero
Cletus A. Arciero
JYJing Yang
Jing Yang
LPLimin Peng
Limin Peng
KWKevin C. Ward
Kevin C. Ward
RORuth O’regan
Ruth O’regan
XLXiaoxian Li
Xiaoxian Li

1 September 2006 in Journal of the National Comprehensive Cancer Network
Verified
Journal Article
Closed access
PDF file
CACletus A. Arciero
Cletus A. Arciero
ESElin R. Sigurdson
Elin R. Sigurdson
Hepatocellular carcinoma (HCC) is a major cause of cancer-related death worldwide. This disease can be treated through several surgical and nonsurgical approaches. Although the only curative options for patients with HCC are surgical (resection or transplantation), most patients unfortunately present with advanced neoplastic disease or experience the effects of chronic liver disease, making surgical resection implausible. Several additional options are available for treating this population. Ablative therapies such as percutaneous ethanol injection, cryotherapy, radiofrequency ablation, laser ablation, and microwave hyperthermic ablation can be used with varying degrees of success. Transarterial chemoembolization can be used in patients with advanced disease or advanced chronic liver disease that cannot be treated with resection or ablation. This article explores the various liver-directed therapies, including surgical resection, and defines morbidity, mortality, and survival for each.